Compare D R Horton Inc (DHI) vs BIO-TECHNE Corp (TECH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
D R Horton Inc vs BIO-TECHNE Corp — how do they compare? D R Horton Inc trades at $135.82 (market cap $37.28B), while BIO-TECHNE Corp trades at $72.46 (market cap $11.37B). The key difference: D R Horton Inc is far larger — about 3.3× BIO-TECHNE Corp's market cap, and D R Horton Inc pays the higher dividend (1.35%). Which is the better fit depends on your goals — on Pluang, investors hold D R Horton Inc for 46 Days and BIO-TECHNE Corp for 63 Days on average.
| DHI | TECH | |
|---|---|---|
Market Cap | $37.28B | $11.37B |
Volume | 3,571,611 | 3,153,511 |
Sector | Consumer Cyclical | Health |
52-Week High | $167.78 | $72.61 |
52-Week Low | $132.53 | $43.31 |
Typical Hold Time | 46 Days | 63 Days |
Enterprise Value | $42.38B | $11.40B |
Dividend Yield | 1.35% | 0.44% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
D.R. Horton (DHI) trades at $135.82, down 0.68% amid broader housing sector pressure from rising mortgage rates. The stock shows bearish technical signals with oversold RSI readings, while fundamentals remain solid with consistent earnings beats and attractive valuation at 12.71 P/E. Recent news highlights sector-wide challenges as mortgage rates approach 7%, though the company maintains strong cash flow generation and dividend payments.
Despite near-term headwinds from rising rates, DHI's strong market position, consistent execution, and discounted valuation present opportunity for long-term investors. Key risks include prolonged housing market weakness and further rate hikes, but analyst consensus remains positive with $156.57 price target suggesting 15% upside potential from current levels.
TECH trades at $72.53, near its 52-week high of $72.70, with a bullish technical signal and strong institutional interest. Recent earnings show mixed results, beating in Q2 2026 but missing in Q1. The company maintains solid profitability with a 65.77% gross margin, though net income declined to $73.40M in 2025. Shareholders approved an acquisition by Merck KGaA at $73.00 per share, a key near-term catalyst.
Outlook is positive due to the pending acquisition, but risks include execution challenges and valuation concerns with a high P/E of 62.53. Analyst consensus is divided with 46% buy ratings, suggesting cautious optimism. The stock offers limited upside to the acquisition price, making it suitable for event-driven investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About D R Horton Inc
D.R. Horton is a leading homebuilder in the United States with operations in 98 markets across 31 states. D.R. Horton mainly builds single-family detached homes (over 90% of home sales revenue) and offers products to entry-level, move-up, luxury buyers, and active adults. The company offers homebuyers mortgage financing and title agency services through its financial services segment. D.R. Horton's headquarters are in Arlington, Texas, and it manages six regional segments across the United States.
Read more on DHI →About BIO-TECHNE Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →
